| Study to Assess the Safety, Tolerability, and Pharmacokinetics of BIIB104 in Healthy Japanese and Non-Japanese Participants (NCT04079101) | Biogen | 2019-10-02 |
| A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder (NCT04007367) | Biogen | 2019-08-06 |
| Study to Evaluate DNL151 in Subjects With Parkinson's Disease (NCT04056689) | Biogen | 2019-07-23 |
| A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT03902002) | Biogen | 2019-07-19 |
| Observational, Postmarketing Surveillance Study of Spinraza Injection (Nusinersen Sodium) (NCT04317794) | Biogen | 2019-07-02 |
| A Real-world Study of Imraldi® Use (NCT04089514) | Biogen | 2019-06-30 |
| Feasibility of the Multiple Sclerosis Performance Test in Participants With Multiple Sclerosis (NCT03926637) | Biogen | 2019-06-17 |
| A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone (NCT04008186) | Biogen | 2019-06-14 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB100 Administered Orally to Adults With Amyotrophic Lateral Sclerosis (NCT03945279) | Biogen | 2019-05-30 |
| A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON (NCT03918447) | Biogen | 2019-05-29 |
| A Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of BIIB091, a Bruton's Tyrosine Kinase (BTK) Inhibitor, in Healthy Adult Participants (NCT03943056) | Biogen | 2019-05-13 |
| Quantitative Magnetic Resonance Imaging (MRI) Sub-Study of MS PATHS (NCT04145284) | Biogen | 2019-04-30 |
| A Human AME Study for Omaveloxolone (NCT03931590) | Biogen | 2019-04-11 |
| Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants (NCT03870763) | Biogen | 2019-03-19 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's Disease (NCT03716570) | Biogen | 2019-03-12 |
| An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) (NCT03749447) | Biogen | 2019-03-08 |
| A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD) (NCT03864614) | Biogen | 2019-02-27 |
| A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Participants With Comorbid Major Depressive Disorder (MDD) and Insomnia (NCT03771664) | Biogen | 2019-02-04 |
| A Study to Evaluate Safety, Tolerability, and Distribution of a Microdose of Radiolabeled BIIB067 (99mTc-MAG3-BIIB067) Co-administered With BIIB067 (Tofersen) to Healthy Adults (NCT03764488) | Biogen | 2018-12-20 |
| A Study of Aducanumab in Participants With Mild Cognitive Impairment Due to Alzheimer's Disease or With Mild Alzheimer's Disease Dementia to Evaluate the Safety of Continued Dosing in Participants With Asymptomatic Amyloid-Related Imaging Abnormalities (NCT03639987) | Biogen | 2018-12-20 |
| A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab Administration (NCT03689972) | Biogen | 2018-11-27 |
| A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder (NCT03672175) | Biogen | 2018-11-19 |
| A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) (NCT03745820) | Biogen | 2018-11-15 |
| A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers (NCT03664453) | Biogen | 2018-10-29 |
| An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis (NCT03573505) | Biogen | 2018-09-24 |
| A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode (NCT03692910) | Biogen | 2018-08-23 |
| One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study (NCT03662919) | Biogen | 2018-07-02 |
| Safety and PK/PD of RTA 1701 in Healthy Adults (NCT03579030) | Biogen | 2018-06-20 |
| Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy (NCT03339336) | Biogen | 2018-05-31 |
| Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease (NCT03352557) | Biogen | 2018-05-03 |
| Evaluating the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Participants (NCT03454126) | Biogen | 2018-03-29 |
| Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy (NCT03283371) | Biogen | 2018-03-20 |
| Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD) (NCT03088956) | Biogen | 2018-01-19 |
| A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX (NCT03366337) | Biogen | 2017-12-26 |
| MS PATHS Normative Sub-Study (NCT02996084) | Biogen | 2017-12-12 |
| Efficacy and Safety of BIIB111 for the Treatment of Choroideremia (NCT03496012) | Biogen | 2017-12-11 |
| A Safety Study of Retinal Gene Therapy for Choroideremia With Administration of BIIB111 (NCT03507686) | Biogen | 2017-11-29 |
| A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis (NCT03347370) | Biogen | 2017-11-27 |
| Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) (NCT03222973) | Biogen | 2017-11-15 |
| A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen (NCT03324685) | Biogen | 2017-11-11 |
| Effect of Itraconazole on the Pharmacokinetics of Bardoxolone Methyl in Healthy Adults (NCT03264079) | Biogen | 2017-10-16 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of BIIB059 in Healthy Japanese Subjects. (NCT03224793) | Biogen | 2017-10-04 |
| A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model (NCT03284931) | Biogen | 2017-09-14 |
| Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074 (NCT03385525) | Biogen | 2017-09-12 |